Lysandro Pinto Borges is a Biochemical Pharmacist from the Federal University of Santa Maria (1998). Borges is a Specialist in Clinical and Toxicological Analysis from UFSM (2000) and a Master and Doctor in Toxicological Biochemistry from UFSM (2008). He served as head of the HGuSM Laboratory (2000-2008). He has taught in ten private universities (1999-2012). He acted as coordinator in five postgraduate courses in the area of Clinical Analysis and Pharmacy. He is the author of five books in the area of health and a reviewer of scientific publications (11 international articles, 4 software registrations, and 1 (one) patent). His research interests include the subareas of Clinical Immunology (SARS-CoV-2 serological tests), Clinical Pharmacology, Clinical Biochemistry, Hormones, Diabetes, Pharmaceutical Care, Pathophysiology, and the development of applications for the health area. He was a substitute professor at UFS and UNIT/SE. He was the tutor of the Residency in Hospital Epidemiology HU/UFS. He is currently Adjunct Professor III at UFS, an ad hoc consultant at FAPITEC/Sergipe, and an advisor in the Masters in Management, innovation, and Health Technologies (PPGITS-HU/UFS). He works in the COVID-19/UFS Task Force, performing clinical analyses in the detection of SARS-CoV-2 (serology, chemiluminescence, and fluorescence)
Lysandro Pinto Borges is a Biochemical Pharmacist from the Federal University of Santa Maria (1998). Borges is a Specialist in Clinical and Toxicological Analysis from UFSM (2000) and a Master and Doctor in Toxicological Biochemistry from UFSM (2008). He served as head of the HGuSM Laboratory (2000-2008). He has taught in ten private universities (1999-2012). He acted as coordinator in five postgraduate courses in the area of Clinical Analysis and Pharmacy. He is the author of five books in the area of health and a reviewer of scientific publications (11 international articles, 4 software registrations, and 1 (one) patent). His research interests include the subareas of Clinical Immunology (SARS-CoV-2 serological tests), Clinical Pharmacology, Clinical Biochemistry, Hormones, Diabetes, Pharmaceutical Care, Pathophysiology, and the development of applications for the health area. He was a substitute professor at UFS and UNIT/SE. He was the tutor of the Residency in Hospital Epidemiology HU/UFS. He is currently Adjunct Professor III at UFS, an ad hoc consultant at FAPITEC/Sergipe, and an advisor in the Masters in Management, innovation, and Health Technologies (PPGITS-HU/UFS). He works in the COVID-19/UFS Task Force, performing clinical analyses in the detection of SARS-CoV-2 (serology, chemiluminescence, and fluorescence)